Skip to main content
. 2020 May 30;9(6):430. doi: 10.3390/pathogens9060430

Table 1.

Liver enzyme abnormalities in COVID-19 disease vary and reflect the degree of inflammatory response, direct biliary injury by the virus, the presence or absence of ischemia/microthromboses, and possible drug-induced liver injury. Hypoalbuminaemia and high transaminases levels are associated with poor prognosis.

Albumin Transaminases GGT Bilirubin Alkaline Phosphatase
COVID-19 Severe liver injury from inflammatory response (cytokine storm) graphic file with name pathogens-09-00430-i001.jpg graphic file with name pathogens-09-00430-i002.jpg Variable graphic file with name pathogens-09-00430-i002.jpg Variable
Drug induced liver injury Variable graphic file with name pathogens-09-00430-i002.jpg Variable Variable Variable
Direct biliary injury Variable Variable graphic file with name pathogens-09-00430-i002.jpg graphic file with name pathogens-09-00430-i002.jpg graphic file with name pathogens-09-00430-i002.jpg
Ischemia/microthrombosis graphic file with name pathogens-09-00430-i001.jpg graphic file with name pathogens-09-00430-i002.jpg Variable graphic file with name pathogens-09-00430-i002.jpg Variable